Swartz Allison sold $30K of PGNY
Swartz Allison (EVP, GC) sold 1,199 shares of Progyny, Inc. (PGNY) at $25.02 on 2026-06-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
This disclosure updates the insider transaction record for PGNY but does not introduce new company fundamentals (no earnings, guidance, deal, or regulatory event).
Market read
Traders may note the insider sale, but the 10b5-1 structure makes it a low-signal event for price discovery.
What to watch
The filing does not indicate whether the executive sold for diversification, tax, or scheduled liquidity needs; without trend context, signal is limited.
Background
SEC Form 4 reports insider transactions; a 10b5-1 plan means trades were pre-scheduled and not necessarily tied to new information.
Ticker impact
Progyny disclosed an EVP/GC open-market sale of 1,199 shares on 2026-06-03 under a pre-arranged 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a routine Form 4 and explicitly states a pre-arranged 10b5-1 plan, reducing interpretive value versus discretionary selling.
Market effects
No direct sector read-through; this is company-specific insider transaction data.
None.
None.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with management’s view of near-term valuation risk, though this single sale is not decisive.
Key entities
- issuerProgyny, Inc.
Company whose shares were sold by an EVP/GC via an open-market transaction under a 10b5-1 plan.
- insiderSwartz Allison
EVP, GC who sold 1,199 shares at $25.0200 on 2026-06-03.
